Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Frontal hypometabolism in elderly breast cancer survivors determined by [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET): a pilot study
Laura L. Boles Ponto, Yusuf Menda, Vincent A. Magnotta, et al.
International Journal of Geriatric Psychiatry (2014) Vol. 30, Iss. 6, pp. 587-594
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults
Jeffrey S. Wefel, Shelli R. Kesler, Kyle R. Noll, et al.
CA A Cancer Journal for Clinicians (2014) Vol. 65, Iss. 2, pp. 123-138
Open Access | Times Cited: 457
Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management
Ben Fleming, Paul Edison, Laura Kenny
BMJ (2023), pp. e071726-e071726
Closed Access | Times Cited: 42
Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer
Gwen Schroyen, Jeroen Blommaert, Donatienne Van Weehaeghe, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4198-4198
Open Access | Times Cited: 42
PET Evidence of the Effect of Donepezil on Cognitive Performance in an Animal Model of Chemobrain
Ilhan Lim, Hye-Young Joung, Abigail Yu, et al.
BioMed Research International (2016) Vol. 2016, pp. 1-7
Open Access | Times Cited: 45
A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors
Charlotte Kerstens, Hans Wildiers, Gwen Schroyen, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1215-1215
Open Access | Times Cited: 12
Quantitative evaluation of redox ratio and collagen characteristics during breast cancer chemotherapy using two-photon intrinsic imaging
Shulian Wu, Yudian Huang, Qinggong Tang, et al.
Biomedical Optics Express (2018) Vol. 9, Iss. 3, pp. 1375-1375
Open Access | Times Cited: 34
Chemobrain as a Product of Growing Success in Chemotherapy - Focus On Glia As Both A Victim And A Cure
Piotr Walczak, Mirosław Janowski
Neuropsychiatry (2019) Vol. 09, Iss. 01
Open Access | Times Cited: 30
Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options
Fulvia Di Iulio, Luca Cravello, Jacob Shofany, et al.
Neurological Sciences (2019) Vol. 40, Iss. 9, pp. 1759-1774
Closed Access | Times Cited: 27
Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events
Ana Dias-Carvalho, Mariana Ferreira, Rita Ferreira, et al.
Archives of Toxicology (2021) Vol. 96, Iss. 1, pp. 11-78
Closed Access | Times Cited: 21
How PET/MR Can Add Value for Children with Cancer
Heike E. Daldrup‐Link
Current Radiology Reports (2017) Vol. 5, Iss. 3
Open Access | Times Cited: 28
In vivo neuroimaging and behavioral correlates in a rat model of chemotherapy-induced cognitive dysfunction
Robert Barry, Nellie Byun, Mohammed Noor Tantawy, et al.
Brain Imaging and Behavior (2017) Vol. 12, Iss. 1, pp. 87-95
Closed Access | Times Cited: 25
Blood and neuroimaging biomarkers of cognitive sequelae in breast cancer patients throughout chemotherapy: A systematic review
Gwen Schroyen, Julie Vissers, Ann Smeets, et al.
Translational Oncology (2021) Vol. 16, pp. 101297-101297
Open Access | Times Cited: 19
Measurement, outcomes and interventions of cognitive function after breast cancer treatment: A narrative review
Miaomiao Jia, Xiaojun Zhang, Liyuan Wei, et al.
Asia-Pacific Journal of Clinical Oncology (2020) Vol. 17, Iss. 4, pp. 321-329
Open Access | Times Cited: 16
A systematic review on the use of quantitative imaging to detect cancer therapy adverse effects in normal-appearing brain tissue
Jan Petr, Louise Hogeboom, Pavel Nikulin, et al.
Magnetic Resonance Materials in Physics Biology and Medicine (2021) Vol. 35, Iss. 1, pp. 163-186
Open Access | Times Cited: 14
Subject-specific computational modeling of DBS in the PPTg area
Laura Zitella Verbick, Benjamin A. Teplitzky, Paul Yager, et al.
Frontiers in Computational Neuroscience (2015) Vol. 9
Open Access | Times Cited: 10
Evaluation of the effects of chemotherapy on brain glucose metabolism in children with Hodgkin’s lymphoma
Alban Tauty, Vincent Noblet, Catherine Paillard, et al.
Annals of Nuclear Medicine (2019) Vol. 33, Iss. 8, pp. 564-569
Closed Access | Times Cited: 10
Functional Imaging of Chemobrain: Usefulness of Nuclear Medicine in the Fog Coming After Cancer
Agostino Chiaravalloti, Luca Filippi, Marco Pagani, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 4, pp. 508-514
Open Access | Times Cited: 3
Cerebral glucose changes after chemotherapy and their relation to long-term cognitive complaints and fatigue
Gwen Schroyen, Georg Schramm, Donatienne Van Weehaeghe, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Cognitive Dysfunction in Older Breast Cancer Survivors
Adele Crouch, Victoria L. Champion, Diane Von Ah
Cancer Nursing (2020) Vol. 45, Iss. 1, pp. E162-E178
Open Access | Times Cited: 7
Cerebral Blood Flow and its Connectivity Deficits in Patients With Lung Cancer After Chemotherapy
Yujie Zhang, Song’an Shang, Lanyue Hu, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 4
A data-driven approach to improve wellness and reduce recurrence in cancer survivors
Ramkumar Hariharan, Leroy Hood, Nathan D. Price
Frontiers in Oncology (2024) Vol. 14
Open Access
Neuropsychological manifestations of chemotherapy
Fernando Santos-Pinheiro, Alissa M. Butts
Elsevier eBooks (2024), pp. 181-197
Closed Access
Longitudinal cognitive function and brain metabolites in women receiving chemotherapy for stage 1 to 3 breast cancer: Observational study
Johanna Beyer, Ronan E. Couch, Kathryn J. Ruddy, et al.
Medicine (2023) Vol. 102, Iss. 42, pp. e35524-e35524
Open Access | Times Cited: 1
Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study
Giorgia Abete-Fornara, Petra Bintintan Socaciu, Claudia Fanizzi, et al.
Journal of Neuro-Oncology (2023) Vol. 165, Iss. 3, pp. 561-568
Open Access | Times Cited: 1
Altered Regional Brain Glucose Metabolism in Diffuse Large B-Cell Lymphoma Patients Treated With Cyclophosphamide, Epirubicin, Vincristine, and Prednisone: An Fluorodeoxyglucose Positron Emission Tomography Study of 205 Cases
Yuxiao Hu, Qin Zhang, Can Cui, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top